Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Regulatory News (SHP)

  • There is currently no data for SHP

Rule 2.9 Announcement

14 Dec 2018 07:00



Rule 2.9 Announcement

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

14 December 2018

Shire plc

(“Shire” or the “Company”)

Rule 2.9 Announcement

In accordance with Rule 2.9 of the City Code on Takeovers and Mergers, the Company confirms that, as at the close of business on 13 December 2018, being the last business day prior to the date of this announcement, it had 924,178,050 ordinary shares of 5 pence each in issue and admitted to trading on the main market of the London Stock Exchange. Shire holds 7,357,283 ordinary shares in treasury. Accordingly, the total number of voting rights in Shire is 916,820,767. The International Securities Identification Number (“ISIN”) for Shire’s ordinary shares is JE00B2QKY057.

Shire has an American Depositary Share (“ADS”) programme for which Citibank, N.A. acts as depositary. One ADS represents three ordinary shares of 5 pence each, with ISIN US82481R1068. The ADSs trade on the NASDAQ Global Select Market.

Enquiries:

Shire plc

Christoph Brackmann (Investor Relations) +41 41 288 4129Sun Kim (Investor Relations) +1 617 588 8175Katie Joyce (Media) +1 781 482 2779


Date   Source Headline
4th Dec 201810:46 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
4th Dec 201810:45 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
4th Dec 201810:44 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
4th Dec 201810:42 amRNSForm 8.5 (EPT/RI)
4th Dec 201810:34 amRNSForm 8.5 (EPT/RI)- Shire plc
4th Dec 201810:31 amRNSForm 8.5 (EPT/NON-RI) - SHIRE PLC
4th Dec 20189:11 amRNSForm 8.3 - Shire plc
4th Dec 20187:00 amGNWRule 2.9 Announcement
3rd Dec 20183:28 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
3rd Dec 20183:28 pmRNSForm 8.5 (EPT/NON-RI)
3rd Dec 20183:26 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
3rd Dec 20183:26 pmRNSForm 8.3 - Shire Plc
3rd Dec 20183:24 pmRNSForm 8.3 -Shire plc
3rd Dec 20183:24 pmRNSForm 8.3 - Shire plc
3rd Dec 20183:20 pmRNSForm 8.3 - Shire plc
3rd Dec 20183:20 pmGNWDavidson Kempner Capital Management LP : Form 8.3 - Shire PLC
3rd Dec 20183:20 pmBUSForm 8.3 - Shire PLC
3rd Dec 20183:01 pmRNSForm 8.3 - Shire Plc
3rd Dec 20183:00 pmBUSForm 8.3 - Shire PLC
3rd Dec 20182:45 pmEQSForm 8.3 - The Vanguard Group, Inc.: Shire plc
3rd Dec 20182:21 pmBUSForm 8.3 - SHIRE PLC
3rd Dec 20182:15 pmRNSForm 8.3 - [Shire Plc]
3rd Dec 20182:03 pmRNSForm 8.5 (EPT/NON-RI)
3rd Dec 20181:56 pmRNSForm 8.5 (EPT/RI) - Replacement of SHIRE
3rd Dec 20181:49 pmRNSForm 8.5 (EPT/RI) - Replacement of SHIRE PLC
3rd Dec 20181:43 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
3rd Dec 20181:40 pmRNSForm 8.3 - Shire plc
3rd Dec 201812:39 pmRNSForm 8.3 - Shire plc
3rd Dec 201812:34 pmRNSForm 8.3 - shire plc
3rd Dec 201812:34 pmRNSForm 8.3 - Takeda Pharmaceutical
3rd Dec 201812:00 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
3rd Dec 201811:57 amRNSForm 8.5 (EPT/RI)
3rd Dec 201811:39 amRNSForm 8.5 (EPT/NON-RI)- Shire Plc
3rd Dec 201811:26 amRNSForm 8.5 (EPT/NON-RI)
3rd Dec 201811:06 amRNSForm 8.5 - Shire Plc
3rd Dec 201810:51 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
3rd Dec 201810:50 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
3rd Dec 201810:48 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
3rd Dec 201810:40 amRNSForm 8.5 (EPT/RI)- Shire plc
3rd Dec 201810:35 amRNSForm 8.5 (EPT/NON-RI) - SHIRE PLC
3rd Dec 201810:25 amRNSForm 8.5 (EPT/RI)
3rd Dec 20189:53 amRNSForm 8.3 - Shire Plc
3rd Dec 20189:25 amRNSForm 8.3 - Shire Plc
3rd Dec 20187:38 amRNSForm 8.3 - Shire plc
3rd Dec 20187:21 amRNSStatement regarding Loan Agreement
3rd Dec 20187:00 amRNSForm 8.3 - Shire Plc
3rd Dec 20187:00 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
3rd Dec 20187:00 amGNWRule 2.9 Announcement
3rd Dec 20187:00 amGNWTotal voting rights
30th Nov 20183:20 pmRNSForm 8.3 - Shire plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.